QSAR, Pharmacophore and Molecular Docking Studies for the Design of Novel Arylamide-derived Inhibitors of Mycobacterium tuberculosis
Adama Niaré, Abadê Ange-Boris N’guessan, Akassa Marius Bernard Djako, Georges Stephane Dembele, Mamadou Guy-Richard Koné & Yaya Yéo · Chemical Science International Journal · 2024
Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It remains a significant public health challenge worldwide. In 2022, approximately 10.6 million people were diagnosed with tuberculosis, and 1.3 million individuals lost their lives to the d...